drugset / Trial / NCT00929266

Cultured Red Blood Cells : Life Span in Vivo Study

NCT00929266 ↗

Completed 1 enrolled Etablissement Français du Sang
NaSingle-groupOpen-labelHealth-services research

Summary

To study the in vivo life span in healthy volunteers of red blood cells generated in vitro from autologous peripheral stem cells. The study will be carried out in 4 phases : * production in vitro of the equivalent of 1 ml of blood, i.e. 5x10e9 enucleated RBC from mononuclear cells isolated from an HSC graft obtained from a healthy volunteers donor. * labeling of these cRBC with 51 Cr * reinjection of the autologous cRBC * follow up of the receivers for a maximum 33 days to measure the half-life span of the injected cells.

Timeline

Start
2010-05
Primary completion
2011-11
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cultured Red Blood Cells Cell therapy 1 ml Intravenous

Indications

No indication recorded.